Your browser doesn't support javascript.
loading
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Hing, Zachary A; Mantel, Rose; Beckwith, Kyle A; Guinn, Daphne; Williams, Erich; Smith, Lisa L; Williams, Katie; Johnson, Amy J; Lehman, Amy M; Byrd, John C; Woyach, Jennifer A; Lapalombella, Rosa.
Afiliação
  • Hing ZA; Medical Scientist Training Program, Division of Hematology, Department of Internal Medicine.
  • Mantel R; Division of Hematology, Department of Internal Medicine.
  • Beckwith KA; Medical Scientist Training Program, Division of Hematology, Department of Internal Medicine.
  • Guinn D; Division of Hematology, Department of Internal Medicine.
  • Williams E; Division of Hematology, Department of Internal Medicine.
  • Smith LL; Division of Hematology, Department of Internal Medicine.
  • Williams K; Division of Hematology, Department of Internal Medicine.
  • Johnson AJ; Division of Hematology, Department of Internal Medicine, Division of Medicinal Chemistry, College of Pharmacy, and.
  • Lehman AM; Center for Biostatistics, The Ohio State University, Columbus, OH.
  • Byrd JC; Division of Hematology, Department of Internal Medicine, Division of Medicinal Chemistry, College of Pharmacy, and.
  • Woyach JA; Division of Hematology, Department of Internal Medicine.
  • Lapalombella R; Division of Hematology, Department of Internal Medicine.
Blood ; 125(20): 3128-32, 2015 May 14.
Article em En | MEDLINE | ID: mdl-25838351
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Triazóis / Leucemia Linfocítica Crônica de Células B / Resistencia a Medicamentos Antineoplásicos / Hidrazinas / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Triazóis / Leucemia Linfocítica Crônica de Células B / Resistencia a Medicamentos Antineoplásicos / Hidrazinas / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article